;)
07-19-2023 
We look forward to the World AMR Conference September 7-8 in Philadelphia, where our CEO, Lloyd Payne will be attending.
ArrePath will be attending the 2023 ASM/ESCMID Joint Conference on Drug Development to Meet the Challenge of Antimicrobial Resistance happening on Sept. 19-22, 2023 in Boston, Mass. where you’ll hear the latest updates in drug development and antimicrobial resistance.
02-27-2023 
ArrePath will be attending the 7th AMR Conference, March 16-17, Basel, Switzerland, where our CEO, Lloyd Payne and founder Zemer Gitai will be attending.
01-27-2023 
ArrePath is looking forward to taking part in BioInfect 2023 on February 1, 2023
11-18-2022 
ArrePath today announced that it has appointed two new members to its Scientific Advisory Board (SAB): Connor Coley, PhD, Henri Slezynger (1957) Career Development Assistant Professor in Chemical Engineering at MIT, and Paul Hergenrother, PhD, Kenneth L. Rinehart Jr. Endowed Chair in Natural Products Chemistry, and Professor of Chemistry at the University of Illinois Urbana-Champaign.
11-10-2022 
ArrePath is presenting at MassBio Innovation Week, December 6, 2022
08-25-2022 
ArrePath will be attending the seventh annual CytoData meeting, hosted by the Allen Institute for Cell Science, which will take place October 17-20, 2022 in Seattle, Washington.
ArrePath is attending the World Anti-Microbial Resistance Congress taking place on September 7-8, 2022, in National Harbor, MD.
Join ArrePath at 2022 NeurIPS, a premier conference on Machine Learning and AI. This event is taking place at the New Orleans Convention Center on Monday, November 28th – Friday, December 9th.
ArrePath today announced the appointment of Michael Dudley, PharmD, as Chairman of the Company’s Board of Directors.